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Genotype-by-Sex Interaction in the Regulation of High-Density

Lipoprotein: The Framingham Heart Study
M. J. MOSHER,1 L. J. MARTIN,2 L. A. CUPPLES,3 Q. YANG,3 T. D. DYER,4 J. T. WILLIAMS,4
AND K. E. NORTH1

Abstract Low levels of high-density lipoprotein (HDL) are widely documented as a risk factor for cardiovascular disease (CVD). Furthermore, there

is marked sexual dimorphism in both HDL levels and the prevalence of
CVD. However, the extent to which genetic factors contribute to such dimor-

phism has been largely unexplored. We examined the evidence for genotype-

by-sex effects on HDL in a longitudinal sample of 1,562 participants from
330 families in the Framingham Heart Study at three times points corre-

sponding approximately to 1971-1974, 1980-1983, and 1988-1991. Using
a variance component method, we conducted a genome scan of HDL at each

time point in males and females, separately and combined, and tested for
genotype-by-sex interaction at a quantitative trait locus (QTL) at each time
point. Consistent findings were noted only for females on chromosome 2
near marker D2S1328, with adjusted LOD scores of 2.6, 2.2, and 2.1 across
the three time points, respectively. In males suggestive linkage was detected

on chromosome 16 near marker D16S3396 at the second time point and
on chromosome 18 near marker D18S851 at the third time point (adjusted
LOD = 2.2 and 2.4, respectively). Although the heritability of HDL is similar in males and females, sex appears to exert a substantial effect on the
QTL-specific variance of HDL. When genotype-by-sex interactions exist and
are not modeled, the power to detect linkage is reduced; thus our results may
explain in part the paucity of significant linkage findings for HDL.

Cardiovascular disease (CVD) is the leading cause of death in the United States

(Arias et al. 2003). A major risk factor for CVD is high-density lipoprotein
(HDL), identified nearly 30 years ago (Gordon et al. 1977). Since the original
study, low plasma HDL levels have been associated with a greater prevalence of
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CVD throughout the world (de Backer et al. 1998). The association between
HDL and CVD may be explained in part by HDL physiology. HDL, the primary
constituent of the reverse cholesterol transport system, returns excess cholesterol
from peripheral tissues to the liver for recycling or excretion. In addition, it medi-

ates physiological traits connected to endothelial function, possesses antithrombotic properties, inhibits monocyte adhesion to vascular walls, and may act as an

antioxidant (Barter et al. 2003). However, plasma HDL exhibits striking sexual
dimorphism, which is expressed as higher HDL levels and lower CVD prevalence
in females (Reilly et al. 1990; Barrett-Conner 1997). Factors underlying this dimorphism are not fully understood.
HDL is a complex trait influenced by both environment and genes (Wilson

et al. 1994; Snieder et al. 1997). Environmental factors known to influence
plasma HDL levels include smoking (Williams 1992), dietary patterns and alco-

hol intake (Perusse et al. 1997a; Friedlander et al. 2000), glucose metabolism
(Tall 1990), adiposity (Stevens et al. 1993), sex hormones (Wu and von Eckard-

stein 2003), and age (Ordovas 2002). From a genetic standpoint a variety of
family studies have reported that HDL has the highest heritability ( h 2) of the
lipid subfractions, with estimates ranging from 40% to 70% (Mitchell et al. 1996;

Duggirala et al. 2000; Hokanson et al. 2003). Genome scans in several populations further identified regions of interest linked to HDL levels, although with
relatively low LOD scores (Ordovas 2002), except for a region on chromosome

16q21 identified in Mexican Americans with a LOD = 4.3 (Mahaney et al.
2003).
One reason that few studies have identified significant linkage to HDL may
be genotype-by-sex interaction, which, when present, reduces the power to localize quantitative trait loci (QTLs), although sex-specific QTLs that influence vari-

ation in HDL levels have been identified in animal studies (Kloting et al. 2001;

Anunciado et al. 2003; Korstanje et al. 2004a). Recent studies have identified
sex-specific HDL variation associated with several environmental factors: dietary

patterns (Mosher et al. 2005; Vega-Lopez et al. 2001), alcohol (Gardner et al.
2000), glucose metabolism (Mittendorfer 2005), and patterns of adiposity and
energy expenditure (Legato 1997; Gardner et al. 2000). Candidate gene studies,
which focus on genes known to affect lipoprotein metabolism, have identified

genes associated with plasma HDL levels (Kessling et al. 1992; Acton et al.
1999a; Pallaud et al. 2001; Ordovas 2002), with several studies reporting genotype-by-sex interaction affecting HDL associated with variants of the APOA1
(Kessling et al. 1992; Sigurdsson et al. 1992; Saha et al. 1994), APOB, and CETP
(Kessling et al. 1992) genes. An extensive study of APOE variants now suggests
that data combining males and females may lead to inferences about gene effects
that do not accurately reflect true gene influence in either sex (Stengard et al.
2002).
We previously reported evidence for a QTL on chromosome 2q that influences HDL variation in a longitudinal sample of female Framingham Heart Study
participants (North et al. 2003). Although the QTL was detected in the combined
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sample of males and females at the first time point, linkage was not significant at

subsequent time points. These previous analyses were conducted on data furnished to the Genetic Analysis Workshop 1 3 and lacked several relevant variables

and possibly limited the outcome. Moreover, male-specific linkage results were
not considered. In this paper we further examine the evidence for sex-specific
linkage of HDL in Framingham Heart Study participants and include additional
variables that may affect genotype-by-sex variation: menopausal status, hormone
therapy, and lipid-lowering drugs.

Methods

Population. The Framingham Heart Study has remained an ongoing project
since its inception in 1948. Data collection began with 5,209 subjects (ages
28-62 years) in 1948, and offspring of the original cohort were added in 1971
as well as spouses. Follow-up visits occurred every two or four years for the
cohort and offspring groups, respectively. The longitudinal study design and

methods have been previously documented (Dawber et al. 1951; Kannel et al.
1979). For the purpose of this study data from all participant generations were
included from three time points, approximately 8 years apart. We assessed fasting

HDL levels, choosing early observations to obtain maximum sample size. These
time points, designated for this study as tu t2 , and t3 , refer to visits 11, 15, and

20 in the original cohort and visits 1, 2, and 4 in the offspring and spouses and

correspond to 1971-1974, 1980-1983, and 1988-1991, respectively.
We selected individuals measured at all the exams of interest who had

complete phenotypic data on age, sex, and cohort effects and included additional
variables of smoking and drinking history, lipid-lowering drugs, menopause, es-

trogen use, and BMI. Fewer than 10 outliers (defined for this study as those
observations beyond four standard deviations from the global mean) were removed, thus reducing the effects of nonnormality or kurtosis on linkage analysis.
Kurtosis values in visits tu t2 , and t3 were 0.3, 0.5, and 0.4, respectively, in the
combined-sexes data. Kurtosis for males in these time periods was 0.52, 0.58,
and 0.73 and in females, 0.43, 0.19, and 0.19, respectively. The resulting sample
analyzed for this study included 1,562 individuals (766 males and 796 females),
representing nearly 3,300 relative pairs in 330 pedigrees: 663 parent-offspring
pairs, 1,273 sibling pairs, 445 avuncular pairs, and 717 pairs of first cousins.

Genotyping. DNA was obtained from 330 Framingham Heart Study families
(ranging in size from 2 to 7) and was sent to the Mammalian Genotyping Service
at the Marshfield Clinic (Marshfield, Wisconsin; http://research.marshfieldclinic

.org/genetics). Using Weber marker set 9, we constructed a 10-cM density genome-wide map. The average heterozygosity of the sex-averaged markers for this

population was 0.77 (Yuan et al. 1997). Genotype data cleaning was completed,
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including verifications of family relationships and checks for Mendelian incon-

sistencies using "sibkin" in the Aspex program (Hinds 1996) and "gentest," a
precursor of "infer" in PEDSYS (Dyke 1994).
To determine the physical location of significant markers and to search for
candidate genes, we used three data banks: University of California, Santa Cruz
(http://genomeAicsc.edu); Wellcome Trust, Sanger Institute (http ://ww w.sanger
.ac.uk/); and Online Mendelian Inheritance in Man (http://www3.ncbi.nlm.nih

.gov/entrez/query.fcgi?db = OMIM).

Phenotyping. To determine HDL levels, we collected blood samples after a
12-hr fast in tubes containing 0.1% EDTA. Plasma was separated by centrifugation, and lipids were immediately analyzed. HDL was measured after precipitating out non-HDL lipoproteins (those containing apolipoprotein B) with dextran
sulfate and magnesium sulfate (Ordovas et al. 2002).
Additional data were collected through standardized questionnaires. Menopause was defined as the cessation of menstrual periods for more than 1 year.
Hormone replacement therapy was defined as the use of oral Premarin or patch

estrogen. Information was also available on the use of lipid-lowering drugs.
Drinking history was documented as the typical amount (in grams) of alcohol
consumed per day during the year before the examination. Smoking history was
defined as the typical number of cigarettes smoked per day during the 1 year
before the date of examination (Gebara et al. 1995; Saccone et al. 2003).

Analysis
Covariate Adjustment. Descriptive statistics and stepwise multivariate regression were calculated using SPSS 10 to determine significant covariates of
HDL to be considered in the genetic model. Subsequently, using SOLAR, version
2.1.2, we screened for statistically significant covariates from a list of covariates

that have been shown to affect HDL variation: age, age by sex, cohort, BMI,
drinking and smoking histories, blood pressure, lipid-lowering medications,
menopause status, and estrogen therapy (Stevens et al. 1993; Perusse et al. 1997a;
Friedlander et al. 2000; Wu and von Eckardstein 2003). We retained those covariates whose effects were significant at a/? ^ 0.10 in the initial analysis, regardless
of whether the significance levels decreased after inclusion of other covariates.
We constructed two models for comparison, one using a minimum adjustment
strategy (adjusting for age, age squared, age-by-sex, and cohort effects) and the
second model adjusted for BMI, smoking and drinking history, lipid-lowering
drugs, menopause, and estrogen therapy for women, or BMI, smoking and drinking history, and lipid-lowering drugs for men.

Genotype-by-Sex Interaction. To examine the evidence for genotype-by-sex
interaction on HDL levels, we used a three-step approach. We first tested for
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evidence of additive genotype-by-sex interaction in the polygenic model. Second,

we compared the results from a linkage analysis of males and females (sexstratified subsets) to the results of an analysis including both males and females

(combined sample) to restrict the number of regions considered in the QTLspecific genotype-by-sex interaction analysis. Last, we examined the evidence for

a QTL-specific genotype-by-sex interaction at regions identified in the linkage

analysis. SOLAR version 2.1.2 was used for all quantitative genetic analyses
(Almasy and Blangero 1998).
Additive Genotype-by-Sex Interaction. Univariate quantitative genetic analysis was done to partition the phenotypic variance of HDL into its additive sexspecific genetic and environmental components using maximum-likelihood variance decomposition methods (Robertson 1959; Eisen and Legates 1966; Comuz-

zie et al. 1993). The expected genetic covariance between a male and female
relative pair /, j is defined as

Cov(gt Af, gjF) = 2(f>ijpg(M F)(jgMcrg F (1)

where 0 is the coefficient of kinship between the two individua
additive genetic correlation between the expressions of the trait

and agM and ag F are the respective genetic standard deviation
females, respectively. In the absence of additive genotype-by-se
the null hypothesis), the genetic correlation between male and

pairs should be pg(M,F ) - 1.0, and male and female genetic stan
will be identical ( crgM = crgtF). Conversely, if there is additive
interaction, the genetic correlation between the sexes will be s
than 1.0 and/or the genetic standard deviations will not be equ
sexes. The likelihood of the model including an additive genotyp
tion was compared to the likelihood of the restricted model in w
tion was excluded using a likelihood-ratio test.

Variance Components Linkage Analysis. To identify region

of genotype-by-sex interaction, we completed a multipoint scan
somes, in the combined-sexes sample, and also in samples strat

gions of interest were identified as those with LOD scores grea

to 1.77 (suggestive evidence for linkage; Rao and Gu 2001) a

that appeared to differ by sex. Genome scans for HDL were pe
both covariate adjustment strategy models at each of the three
estimate multipoint identical-by-descent probabilities, a pairwis

lihood-base procedure was used, with an extension of Fulk

(1996) technique, to permit the multipoint analysis for quantit

mapping (Almasy and Blangero 1998). Using a variance com

(Blangero and Almasy 1997), we tested the null hypothesis that
netic variance resulting from a QTL (cr^) equals 0 (no linkage) b
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likelihood of this restricted model with that of a model in which a2q is estimated.
The difference between the two log10-likelihoods produces a LOD score that is

the equivalent of the classical LOD score of linkage analysis. Twice the difference in log-likelihoods of these models yields a test statistic that is asymptotically distributed as a ^ ^ mixture of a chi-square variable and a point mass at 0

(Hopper and Mathews 1982).
To verify our major linkage findings, we calculated the adjusted distribution
of the LOD scores under the assumption of multivariate normality, using 10,000

replicates and simulation methods incorporated into SOLAR (Almasy and Blangero 1998). We then used the adjusted distribution of the simulated LOD scores
to assign percentiles to each replicate and calculated an expected test statistic on
the basis of the percentile. SOLAR produces a correction constant by regressing
the expected LOD scores on the observed simulated LOD scores, which we used

to determine an adjusted LOD score [adjusted LOD score = observed LOD
score X correction constant (Blangero et al. 2001)]. All correction constants were
0.88 or greater.

QTL-Specific Genotype-by-Sex Interaction. In the regions identified by
comparison of genome scans of males, females, and the combined-sexes sample,
we extended the additive genotype-by-sex interaction to include a QTL-specific
component by including two more parameters: the QTL-specific standard deviation for males and for females (Towne et al. 1999). The expected genetic covariance between a male and female relative pair /, j is defined as

Cov(gi Af, gjF) = 2(f>ijpg(MtF)crg Mcrg F 4- 7rqiJcrqMcrqF (2)
where 7rqij is the probability that individuals i and j are identical by descent at a
QTL that is linked to a genetic marker locus, and aq M and aq F are the markerspecific genetic standard deviations for males and females, respectively. To test
for QTL-specific genotype-by-sex interaction, we compared the likelihood of the
model in which the male and female marker-specific standard deviations are constrained to be equal {crqM = aq>F) (i.e., the null hypothesis) to the likelihood of a
general model in which all additive and QTL-specific parameters are estimated.
Using a chi-square test with 1 degree of freedom, we compared the likelihood of
this model including a QTL-specific genotype-by-sex interaction to the likelihood of the restricted model in which such interaction was excluded using a
likelihood-ratio test (Self and Liang 1987; Williams et al. 1999a, 1999b).

Results

Descriptive Statistics. HDL levels were consistently lower in males than in
females in both cohorts over all three time periods (Table 1). HDL levels and age
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Table 2. Residual Heritability for HDL in Males, Females, and the Combined-Sexes
Sample
Visit
ti

Sample

Heritability

Males3

0.62

Females3

(±

SE)

±0.10

0.48

±0.10

Combined13 0.42 ± 0.05
t2

Males

0.50

Females
Combined

h

Males

0.51

Females

a.

Adjusted
Adjusted

for
for

age,
age,

±0.10

0.42

±

±

0.05

0.09

0.38

Combined

b.

±0.10

0.41

±

0.42

age2,

0.09

±

0.05

and

age2,

cohort.

age

by

sex,

age

were not statistically associated
ated with age in females at t' (p
females at t3(p = 0.003). Males an
ally overweight, as illustrated by
tx and t2 were within the norma
reporting menopause in t3 was do
taking estrogen was consistently
centage of both males and fema
less than 3.4% for all time period

After accounting for covariat
HDL in the combined-sexes samp

heritability was similar at all tim
drinking history, lipid-lowering
for women, and BMI, smoking a
for men changed the heritabilit

Additive
by-sex

tions

Genotype-by-Sex

interactions

larger

in

for

males

HDL

than

In

at

in

al
fem

between males and females ( pg(
cantly different from the gener
(pg

= 0.003 ± 0.10 for tl9 pg = 0
all P <0.001). The implication is
effects on HDL in males and fem
the

male
was

such

and

female

significantly

interaction

was

genetic

stan

different

allowed

P ^ 0.03) and t2 = 9.80 ± 0.89, = 12.99 ± 1.04, P ^ 0.04) only. The

This content downloaded from 140.160.178.140 on Fri, 01 Mar 2019 18:31:26 UTC
All use subject to https://about.jstor.org/terms

fr

for

Genotype-by-Sex Interaction and HDL / 781
Table 3. Adjusted LOD Scores > 1 .T for HDL Across Three Time Points in the Combined-Sexes Sample and Stratified by Sex
Visit Sample Chromosome Locus Adjusted LOD Score

1

1

Femalesb
Females

2

133

2.6

12

170

1.8

Combined0
Combined

t2

Males

2

150

3.1

12

170

2.1

16

Combined

f3

Males

18

Females

a.
c.

2

Criteria

b.

79
1

2.2

12

75

2.2

2.4

132

for

2.1

suggestiv

Sex-stratified
Analysis

of

implication

analysis

combined

is

that

and females.

Variance Components Linkage Analysis. Table 3 presents the adjusted LOD
scores from our multipoint genome- wide scan using the minimum model and the

location for all peaks greater than or equal to 1.77. Only the results using the
minimum adjustment strategy are presented, because the adjusted LOD scores
obtained using the Model 2 adjustment strategy were similar. Although the heritability of HDL is not significantly different in males and females, sex does
appear to exert a substantial effect on the QTL-specific variance of HDL.
In the combined-sexes sample we obtained an adjusted LOD score of 3.1
on chromosome 2 at 150 cM for the tx observation. At t2 and t3 this region did
not reach statistical significance, with adjusted LOD scores of 0.5 at 120 cM and

1.0 at 122 cM, respectively. Two other signals in the combined-sexes sample
reached statistical significance: At tx the adjusted LOD score was 2.1 on chromosome 12 at 170 cM, and at t2 the adjusted LOD score was 2.2 on chromosome 1
at 12 cM.

However, when stratifying the sample by sex, we documented a consistent
finding of linkage in females on chromosome 2 near marker D2S1328 at 2ql4.3
in all three time periods, with adjusted LOD scores of 2.6 at tu 1.7 at t2 , and 2.1
at t3 (Figure 1). The one LOD unit support interval (SI) of the chromosome 2

signal in females spans 39 cM and 47 MB. A second location suggestive of
linkage was identified on chromosome 12, near marker D12S392, with an ad-

justed LOD score of 1.8 at and the SI spanning 25 cM (Figure 2). In the male
subset no linkage was detected in either of these regions (data not shown); however, at 170 cM an adjusted LOD score of 2.1 was detected on chromosome 12
in the combined-sexes sample.
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Figure 1. Adjusted LOD scores on chromosome 2 for HDL cholesterol in females and the combined-sexes sample at three time points. Data from the Framingham Heart Study.

Figure 2. Adjusted LOD scores on chromosome 12 for HDL cholesterol in females and the combined-sexes sample at three time points. Data from the Framingham Heart Study.
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Figure 3. Adjusted LOD scores on chromosome 16 for HDL cholesterol in males and the combined-sexes sample at three time points. Data from the Framingham Heart Study.

In males the results are not consistent across observation time points. We

detected an adjusted LOD score of 2.2 on chromosome 16 at 79 cM (nearest
marker D16S3396, located at 16ql2.1) at t2 (Figure 3). The SI spans 36.5 MB.
We also detected a suggestive linkage peak (adjusted LOD = 2.4) on chromosome 18 at 75 cM (nearest marker DS18S851, located at 18q21.1) at t3 (Figure
4). The SI spans 36 MB. No adjusted LOD scores greater than 1.0 were detected
in females in either of these regions (data not shown); however, at 106 cM an
adjusted LOD score of 1.7 was detected in the combined sample.

QTL-Specific Genotype-by-Sex Interaction. QTL-specific genotype-by-sex
interaction was noted at four chromosomal locations displaying increased linkage

signals in one of the two sex subsets (chromosomes 2, 12, 16, and 18). On chromosome 2 QTL-specific interaction was noted for all three time periods and is

reported in Table 3 (all /)<0.03). In contrast, on chromosome 12, 16, and 18
QTL-specific interaction was noted only at a single time point. QTL-specific
interaction was identified on chromosome 12 for the first time point, on chromo-

some 16 for the second time point, and on chromosome 18 for the third time

point (all P < 0.03).
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Figure 4. Adjusted LOD scores on chromosome 18 for HDL cholesterol in males and the combined-sexes sample at three time points. Data from the Framingham Heart Study.

Discussion
Sexual dimorphism in HDL levels is frequently reported in the literature
(Reilly et al. 1990; Barrett-Conner 1997). However, most linkage studies of HDL

levels have not explicitly explored genotype-by-sex interaction by testing
whether the genes influencing HDL variability are differentially expressed in

males and females. Therefore our objective was to examine the evidence for
sex- specific linkage of HDL in a longitudinal sample of participants from the
Framingham Heart Study. To approach this complex question, we assessed the
evidence for additive genotype-by-sex interaction. In addition, we identified four
regions on the genome that displayed differential evidence of linkage in males
and females. By examining these regions further, we demonstrated sex-specific
QTL effects at each of these loci.
We found strong evidence of additive genotype-by-sex interaction in HDL
levels across all three time periods. The male and female genetic standard deviations were significantly different for time period tu suggesting a different magni-

tude of genetic effects on HDL in males and females. Moreover, the genetic
correlation between males and females was significantly different from 1 across
all three time periods (p < 0.001), suggesting distinct additive genetic effects on
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HDL in males and females. Based on the estimates of pg, the shared genetic
component to the variance in HDL between the sexes in this population appears
to be negligible. However, we must be cautious in interpreting this finding to
specific loci because this is an estimate for additive effects, and thus the lack of
a genetic correlation may be due to oligogenic effects that differ in the sexes

(Carey 1988).
In the sex-specific linkage analysis we identified four regions, only one of
which was identified in the full sample. Although these sex-specific linkages
exhibited only suggestive evidence, these signals overlap previously reported
QTLs associated with HDL and related phenotypes (Table 4). Moreover, the presence of biological candidate genes with sex-specific influence in several of these
regions further supports our hypothesis of sex-specific loci affecting HDL variation.

We also found strong evidence of QTL-specific genotype-by-sex interaction, with suggestive QTLs identified in sex-stratified data on chromosomes 2q

and 12q in females and chromosomes 16q and 18q in males. The inclusion of
the QTL-specific genotype-by-sex component strengthens our findings from the

linkage analysis that was performed in the sex-specific stratum, which was restricted to the relative pairs concordant for sex (826 and 808 male and female
concordant relative pairs, respectively). When formally modeling QTL-specific
interaction, we were able to use the information from the discordant relative pairs
(N = 1,612), thereby increasing our power to detect genetic effects. The formal
testing of QTL-specific genotype-by-sex interaction suggests that the underlying
genetic structure of HDL may be sex specific. Table 5 documents our findings
and the studies that they replicate.
In females the strongest evidence for linkage at chromosome 2q 13.43 coincides with findings associated with lipid phenotypes in two different populations.

This region contains several interleukin 1 (IL1) alpha and beta genes, which
influence inflammation (Lord et al. 1991), as well as IL1 receptor antagonist,
which inhibits IL1 action on endothelial cells (Dinarello and Wolff 1993). Sex
hormones have been shown to influence the expression of IL1 (Morishita et al.

1999). The second finding for females, at chromosome 12q24, also coincides
with a signal reported for triglycerides (Reed et al. 2001). Chromosome 12q24
harbors SCARB1, which is an HDL receptor that regulates cholesterol and triglycerides uptake (McCarthy et al. 2003; Trigatti et al. 2003; Osgood et al. 2003).
Several studies have demonstrated sex-specific effects of this gene on lipoprotein
variation (Acton et al. 1999b; McCarthy et al. 2003).
In males the marker identified at chromosome 16q21.1 coincides with a
region linked to triglycerides in the Framingham Heart Study (Shearman et al.
2000) and several related phenotypes in Mauritian families (Francke et al. 2001).
Our signal is also less than 20 MB from the signal reported for HDL on chromosome 16q22 in Mexican American families (Mahaney et al. 2003). Chromosome

16ql2.1 includes the CETP and LCAT genes. Both have been shown to affect
HDL variation (Brousseau et al. 2002; Ordovas et al. 2000). Genotype-by-sex
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effects have been documented for CETP variants in Israeli (Kark et al. 2000),

Finnish (Kauma et al. 1996), and American (Kastelein et al. 1999) populations,
although some studies have identified female-specific effects and others malespecific effects. Our second finding for males, located at chromosome 18q21.1,
supports the results noted on chromosome 18q21.31 for lipid phenotypes in fami-

lies recruited for the HyperGEN Study (Coon et al. 2001). Chromosome
18q21.31 contains start-domain-containing protein 6 (STARD6), which binds
cholesterol to the mitochondrial P450 cleavage enzymes in steroidogenic cells.
STARD6 is identified as testis specific and is not reported in ovarian tissue. Because STARD6 is involved in cholesterol homeostasis and is testis specific, it is
an interesting candidate for sex-specific linkage signals.
Differences in the genes contributing to the variation in HDL by sex or
differences in the expression of HDL by sex are biologically plausible and are
supported by several lines of evidence. First, sexual dimorphism in HDL levels
is frequently reported in the literature (Reilly et al. 1990; Barrett-Conner 1997).
Second, sex-specific QTLs that influence variation in HDL levels have been identified in animal models (Kloting et al. 2001; Korstanje et al. 2004b). Moreover,
sex-specific QTLs for physiologically related phenotypes, such as serum insulin,
triglyceride, total cholesterol, and phospholipid levels, have also been reported
(Kloting et al. 2001; Anunciado et al. 2003).
This study has several limitations. First, there is a general lack of consistency in linkage results across time periods. One possible interpretation of these
findings is age-dependent changes in the genetic control of HDL levels (Diego et
al. 2003). Clearly, there is evidence of an age-related trend in the sexual dimor-

phism of circulating HDL levels (Williams 1992; Snieder et al. 1997). Such agerelated genetic effects are supported by the sex-specific age trends in HDL varia-

tion. Sexual dimorphism in HDL is first noted during adolescence, when the
concentration of HDL begins to decrease in males and increase in females. The
differences remain throughout the life span, despite some decrease in HDL levels
during the female menopause transition (Snieder et al. 1997; Barrett-Conner
1997). At this time, addressing both genotype-by-sex and genotype-by-age interaction together is not feasible; furthermore, this type of analysis would require
substantially larger sample sizes to achieve appropriate statistical power. How-

ever, the lack of consistency may also be due to stochastic variation in HDL
levels (Diego et al. 2003), environmental factors that change over time, and tem-

poral changes in measurement techniques. A second limitation is the lack of
available information on dietary intake of macronutrients (proteins, fat, and carbohydrate) and energy expenditure. More research to address the effects of diet,

exercise, and age as well as an exploration of relevant candidate gene variants
may further shed light on the underlying genetic architecture of HDL variation.
In conclusion, this study provides strong evidence of genotype-by-sex interaction on circulating HDL levels. In the additive genetic genotype-by-sex interaction analysis, both the genetic standard deviations in males and in females
differed significantly and the genetic correlation was significantly different from
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1 . These results suggest that a different gene or suite of genes is contributing to
the variance of HDL levels in this population. The inference of a suite of different

genes influencing HDL levels in males and females is further supported by the
variance components linkage analyses of the sample stratified by sex, where suggestive evidence for linkage to HDL was identified on two chromosomes in females (chromosomes 2 and 12) and on two chromosomes in males (chromosomes
16 and 18). Furthermore, we identified QTL-specific genotype-by-sex interaction
at these four loci, suggesting a complex genetic architecture to HDL levels that
varies by sex.
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